CD14 and small cell lung carcinoma: Tian T et al. [40] also focus on CD14(+)HLA-DR-/low cells and indicated that increased circulating CD14(+)HLA-DR-/low myeloid-derived suppressor cells (MDSCs) are associated with poor prognosis in patients with small-cell lung cancer (SCLC).